Skoči na glavni sadržaj

Pregledni rad

Pharmacogenetics of Depressions

Neven Henigsberg
Vera Folnegović-Šmalc


Puni tekst: hrvatski pdf 61 Kb

str. 107-111

preuzimanja: 724

citiraj


Sažetak

Pharmacogenetics, and particularly pharmacogenomics,
are new scientific disciplines whose initial
results hold promise that the homogeneous groups with
respect to the expected therapeutic response will be recognized
among people suffering from depression, which would
enable its more efficient treatment.
It is clear that the therapeutic response is a result of complex
genetic effects, and not only of one gene. Therapeutic
response is affected not only by genetic polymorphisms, but
also by variations in gene expression and post-translational
modifications of proteins under the influence of numerous
factors, e.g. dose, food, interactions with other substances.
Although pharmacogenetic or even pharmacogenomic studies
alone are not expected to completely elucidate the variability
in the therapeutic response, the establishment of at
least some causes of this variability, which is under a direct
genetic influence, would significantly contribute to a more
reliable assessment of expected therapeutic response and
considerably increase a currently low share of patients
responding to antidepressant therapies. For the most part,
the variability in the therapeutic response can be explained
only by further transcriptomic and proteomic research that
is, currently, in the early phase of development.

Ključne riječi

pharmacogenetics; antidepressants; pharmacogenomics; human genome

Hrčak ID:

19814

URI

https://hrcak.srce.hr/19814

Datum izdavanja:

26.1.2004.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.776 *